James P. Chambers
Known title: DirectorCIK: 0001778860
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 26, 2026
Dave & Buster's faces mixed analyst views after recent earnings. Analyst opinions on Dave & Buster's are currently split, with BMO maintaining a positive stance while UBS and Freedom Capital remain unconvinced. This divergence follows the company's recent quarterly earnings calls. The stock is trading near its 52-week low, reflecting the cautious sentiment among some investors despite the bullish outlook from others.
Transaction History
| PRKS | ▲ Buy | Grant | 1,592 | $0 | 9/30/2026 | View on chart |
| STKS | ▲ Buy | Grant | 19,531 | $0 | 9/30/2026 | View on chart |
| PLAY | ▲ Buy | Grant | 1,071 | $0 | 8/5/2026 | View on chart |
| STKS | ▲ Buy | Grant | 15,547 | $0 | 6/30/2026 | View on chart |
| PRKS | ▲ Buy | Grant | 1,098 | $0 | 6/30/2026 | View on chart |
| PRKS | ▲ Buy | Grant | 5,404 | $0 | 6/16/2026 | View on chart |
| PLAY | ▲ Buy | Grant | 976 | $0 | 5/6/2026 | View on chart |
| PLAY | ▲ Buy | Grant | 11,278 | $0 | 4/24/2026 | View on chart |
| STKS | ▲ Buy | Grant | 17,556 | $0 | 3/31/2026 | View on chart |
| PRKS | ▲ Buy | Grant | 1,659 | $0 | 3/31/2026 | View on chart |
| PLAY | ▲ Buy | Grant | 583 | $0 | 2/5/2026 | View on chart |
| PLAY | ▲ Buy | Grant | 524 | $0 | 1/27/2026 | View on chart |
| STKS | ▲ Buy | Grant | 17,857 | $0 | 12/31/2025 | View on chart |
| PRKS | ▲ Buy | Grant | 1,409 | $0 | 12/31/2025 | View on chart |
| STKS | ▲ Buy | Grant | 10,557 | $0 | 9/30/2025 | View on chart |
| PRKS | ▲ Buy | Grant | 973 | $51K | 9/30/2025 | View on chart |
| PRKS | ▲ Buy | Grant | 617 | $31K | 8/11/2025 | View on chart |
| STKS | ▲ Buy | Grant | 6,481 | $0 | 6/30/2025 | View on chart |
| PRKS | ▲ Buy | Grant | 1,082 | $51K | 6/30/2025 | View on chart |
| PLAY | ▲ Buy | Grant | 4,760 | $0 | 6/27/2025 | View on chart |
| PRKS | ▲ Buy | Grant | 5,358 | $220K | 6/13/2025 | View on chart |
| STKS | ▲ Buy | Grant | 8,779 | $0 | 3/31/2025 | View on chart |
| PRKS | ▲ Buy | Grant | 1,106 | $0 | 3/31/2025 | View on chart |
| STKS | ▲ Buy | Grant | 9,051 | $0 | 12/31/2024 | View on chart |
| PRKS | ▲ Buy | Grant | 916 | $0 | 12/31/2024 | View on chart |
| PRKS | ▲ Buy | Grant | 438 | $0 | 11/11/2024 | View on chart |
| STKS | ▲ Buy | Grant | 7,133 | $0 | 10/1/2024 | View on chart |
| PRKS | ▲ Buy | Grant | 853 | $0 | 9/30/2024 | View on chart |
| PRKS | ▲ Buy | Grant | 410 | $0 | 8/23/2024 | View on chart |
| PRKS | ▲ Buy | Grant | 805 | $0 | 6/30/2024 | View on chart |
| STKS | ▲ Buy | Grant | 4,117 | $0 | 6/28/2024 | View on chart |
| PRKS | ▲ Buy | Grant | 3,884 | $0 | 6/13/2024 | View on chart |
| PLAY | ▲ Buy | Grant | 2,723 | $0 | 4/24/2024 | View on chart |
| PRKS | ▲ Buy | Grant | 853 | $0 | 3/31/2024 | View on chart |
| PRKS | ▲ Buy | Grant | 1,168 | $0 | 12/31/2023 | View on chart |
| PRKS | ▲ Buy | Grant | 1,054 | $0 | 9/30/2023 | View on chart |
| PRKS | ▲ Buy | Grant | 432 | $0 | 9/30/2023 | View on chart |
| PRKS | ▲ Buy | Grant | 737 | $0 | 6/30/2023 | View on chart |
| PRKS | ▲ Buy | Grant | 2,951 | $0 | 6/13/2023 | View on chart |
| PLAY | ▲ Buy | Grant | 3,739 | $0 | 4/24/2023 | View on chart |
| PRKS | ▲ Buy | Grant | 698 | $0 | 3/31/2023 | View on chart |
| PRKS | ▲ Buy | Grant | 1,546 | $0 | 12/31/2022 | View on chart |
| PRKS | ▲ Buy | Grant | 1,055 | $0 | 9/30/2022 | View on chart |
| PRKS | ▲ Buy | Grant | 1,095 | $0 | 6/30/2022 | View on chart |
| PRKS | ▲ Buy | Grant | 3,935 | $0 | 6/13/2022 | View on chart |
| PLAY | ▲ Buy | Grant | 2,934 | $0 | 4/18/2022 | View on chart |
| PRKS | ▲ Buy | Grant | 558 | $0 | 3/31/2022 | View on chart |
| PRKS | ▲ Buy | Grant | 1,197 | $0 | 12/31/2021 | View on chart |
| PRKS | ▲ Buy | Grant | 576 | $0 | 9/30/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Citi cuts PRKS target to $34, maintains Neutral rating
Citigroup has maintained a Neutral rating on United Parks & Resorts while lowering its price target to $34. This update coincides with the company announcing the date for its third-quarter 2026 earnings release and conference call. The new target sits at the lower end of the current analyst consensus range.
Citi cuts PRKS target to $34, maintains Neutral rating. Citigroup has maintained a Neutral rating on United Parks & Resorts while lowering its price target to $34. This update coincides with the company announcing the date for its third-quarter 2026 earnings release and conference call. The new target sits at the lower end of the current analyst consensus range.